Atlas Trials

A Study to Assess Adverse Events and Change in Disease Activity of HArmonyCa Lidocaine Injectable Gel for Mid Face Soft Tissue Augmentation in Adult Participants

Clinical trial NCT05452070 · COMPLETED

Trial details

NCT number
NCT05452070
Sponsor
Allergan
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Mid Face Volume Deficit
Start date
2022-09-02
Primary completion
2025-05-08
Enrollment
171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.